|
[1]
|
Lassalle, P., Molet, S., Janin, A., et al. (1996) ESM-1 Is a Novel Human Endothelial Cell-Specific Molecule Expressed in Lung and Regulated by Cytokines. Journal of Biological Chemistry, 271, 20458-20464. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Béchard, D., Gentina, T., Delehedde, M., et al. (2001) Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mi-togenic Activity. Journal of Biological Chemistry, 276, 48341-48349. [Google Scholar] [CrossRef]
|
|
[3]
|
Bechard, D., Meignin, V., Scherpereel, A., et al. (2000) Characteri-zation of the Secreted Form of Endothelial-Cell-Specific Molecule 1 by Specific Monoclonal Antibodies. Journal of Vascular Research, 37, 417-425. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Nalewajska, M., Gurazda, K., Marchelek-Myśliwiec, M., et al. (2020) The Role of Endocan in Selected Kidney Diseases. International Journal of Molecular Sciences, 21, 6119. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Balta, S., Mikhailidis, D.P., Demirkol, S., et al. (2015) Endocan: A Novel Inflammatory Indicator in Cardiovascular Disease? Atherosclerosis, 243, 339-343. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zhao, H., Guo, Y., Sun, Y., et al. (2020) miR-181a/b-5p Ameliorates Inflammatory Response in Monocrotaline-Induced Pulmonary Arterial Hypertension by Targeting Endocan. Journal of Cellular Physiology, 235, 4422-4433. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kano, K., Sakamaki, K., Oue, N., et al. (2020) Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy. In Vivo, 34, 461-467. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Sagara, A., Igarashi, K., Otsuka, M., et al. (2017) Endocan as a Prog-nostic Biomarker of Triple-Negative Breast Cancer. Breast Cancer Research and Treatment, 161, 269-278. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Laloglu, E., Aksoy, H., Aksoy, Y., et al. (2016) The Determina-tion of Serum and Urinary Endocan Concentrations in Patients with Bladder Cancer. Annals of Clinical Biochemistry, 53, 647-653. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Scherpereel, A., Gentina, T., Grigoriu, B., et al. (2003) Overex-pression of Endocan Induces Tumor Formation. Cancer Research, 63, 6084-6089.
|
|
[11]
|
Tsai, J.C., Zhang, J., Minami, T., et al. (2002) Cloning and Characterization of the Human Lung Endothelial-Cell-Specific Molecule-1 Promoter. Journal of Vascular Research, 39, 148-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Depontieu, F., Grigoriu, B.D., Scherpereel, A., et al. (2008) Loss of Endocan Tumorigenic Properties after Alternative Splicing of Exon 2. BMC Cancer, 8, 14. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Delehedde, M., Devenyns, L., Maurage, C.A., et al. (2013) Endocan in Cancers: A Lesson from a Circulating Dermatan Sulfate Proteoglycan. International Journal of Cell Biology, 2013, Article ID: 705027. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Scherpereel, A., Depontieu, F., Grigoriu, B., et al. (2006) Endocan, a New Endothelial Marker in Human Sepsis. Critical Care Medicine, 34, 532-537. [Google Scholar] [CrossRef]
|
|
[15]
|
Sarrazin, S., Lyon, M., Deakin, J.A., et al. (2010) Characterization and Binding Activity of the Chondroitin/Dermatan Sulfate Chain from Endocan, a Soluble Endothelial Proteoglycan. Glycobiology, 20, 1380-1388. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Béchard, D., Scherpereel, A., Hammad, H., et al. (2001) Human En-dothelial-Cell Specific Molecule-1 Binds Directly to the Integrin CD11a/CD18 (LFA-1) and Blocks Binding to Intercel-lular Adhesion Molecule-1. Journal of Immunology, 167, 3099-3106. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Balta, I., Balta, S., Koryurek, O.M., et al. (2014) Serum Endocan Levels as a Marker of Disease Activity in Patients with Behçet Disease. Journal of the American Academy of Dermatol-ogy, 70, 291-296. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Kupeli, I., Salcan, S., Kuzucu, M., et al. (2018) Can Endocan Be a New Biomarker in Ventilator-Associated Pneumonia? The Kaohsiung Journal of Medical Sciences, 34, 689-694. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Gaudet, A., Portier, L., Mathieu, D., et al. (2020) Cleaved Endocan Acts as a Biologic Competitor of Endocan in the Control of ICAM-1-Dependent Leukocyte Diapedesis. Journal of Leu-kocyte Biology, 107, 833-841. [Google Scholar] [CrossRef]
|
|
[20]
|
Rocha, S.F., Schiller, M., Jing, D., et al. (2014) Esm1 Modu-lates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF Bioavailability. Circulation Research, 115, 581-590. [Google Scholar] [CrossRef]
|
|
[21]
|
Kao, S.J., Chuang, C.Y., Tang, C.H., et al. (2014) Plas-ma Endothelial Cell-Specific Molecule-1 (ESM-1) in Management of Community-Acquired Pneumonia. Clinical Chem-istry and Laboratory Medicine, 52, 445-451. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Pihtili, A., Bingol, Z. and Kiyan, E. (2018) Serum Endocan Levels in Patients with Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease, 13, 3367-3372. [Google Scholar] [CrossRef]
|
|
[23]
|
Dai, L., He, J., Chen, J., et al. (2018) The Association of Elevated Circulating Endocan Levels with Lung Function Decline in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease, 13, 3699-3706. [Google Scholar] [CrossRef]
|
|
[24]
|
İn, E., Kuluöztürk, M., Turgut, T., et al. (2020) Endocan as a Poten-tial Biomarker of Disease Severity and Exacerbations in COPD. The Clinical Respiratory Journal, 15, 445-453. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Balta, I., Balta, S., Koryurek, O.M., et al. (2014) Mean Platelet Volume Is Associated with Aortic Arterial Stiffness in Patients with Behçet’s Disease without Significant Cardiovascular Involve-ment. The Journal of the European Academy of Dermatology and Venereology, 28, 1388-1393. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Sun, H., Zhang, H., Li, K., et al. (2019) ESM-1 Promotes Adhesion be-tween Monocytes and Endothelial Cells under Intermittent Hypoxia. Journal of Cellular Physiology, 234, 1512-1521. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lee, W., Ku, S.K., Kim, S.W., et al. (2014) Endocan Elicits Severe Vascular Inflammatory Responses in Vitro and In Vivo. Journal of Cellular Physiology, 229, 620-630. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Menon, P., Kocher, O.N. and Aird, W.C. (2011) Endothelial Cell Specific Molecule-1 (ESM-1), a Novel Secreted Proteoglycan Stimulates Vascular Smooth Muscle Cell Proliferation and Migra-tion. Circulation, 124, A15455.
|
|
[29]
|
Kose, M., Emet, S., Akpinar, T.S., et al. (2015) Serum Endocan Level and the Se-verity of Coronary Artery Disease: A Pilot Study. Angiology, 66, 727-731. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Wang, X.S., Yang, W., Luo, T., et al. (2015) Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension. Genetic Testing and Molecular Biomarkers, 19, 124-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Zonda, G.I., Zonda, R., Cernomaz, A.T., et al. (2019) Endocan—A Potential Diagnostic Marker for Early Onset Sepsis in Neonates. The Journal of Infection in Developing Countries, 13, 311-317. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Gaudet, A., Parmentier, E., Dubucquoi, S., et al. (2018) Low En-docan Levels Are Predictive of Acute Respiratory Distress Syndrome in Severe Sepsis and Septic Shock. Journal of Critical Care, 47, 121-126. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
De Freitas Caires, N., Legendre, B., Parmentier, E., et al. (2013) Identification of a 14 kDa Endocan Fragment Generated by Cathepsin G, a Novel Circulating Biomarker in Patients with Sepsis. Journal of Pharmaceutical and Biomedical Analysis, 78-79, 45-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Yang, J., Yang, Q., Yu, S., et al. (2015) Endocan: A New Marker for Cancer and a Target for Cancer Therapy. Biomedical Reports, 3, 279-283. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Shin, J.W., Huggenberger, R. and Detmar, M. (2008) Transcriptional Profiling of VEGF-A and VEGF-C Target Genes in Lymphatic Endothelium Reveals Endothelial-Specific Molecule-1 as a Novel Mediator of Lymphangiogenesis. Blood, 112, 2318-2326. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
del Toro, R., Prahst, C., Mathivet, T., et al. (2010) Identifica-tion and Functional Analysis of Endothelial Tip Cell-Enriched Genes. Blood, 116, 4025-4033. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Roudnicky, F., Poyet, C., Wild, P., et al. (2013) Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A-Induced Angiogenesis. Cancer Research, 73, 1097-1106. [Google Scholar] [CrossRef]
|
|
[38]
|
Cai, H., Yang, X., Gao, Y., et al. (2019) Exosomal Mi-croRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer. Molecular Therapy—Nucleic Acids, 18, 787-800. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Feng, R., Li, Z., Wang, X., et al. (2021) Silenced lncRNA SNHG14 Restrains the Biological Behaviors of Bladder Cancer Cells via Regulating microRNA-211-3p/ESM1 Axis. Cancer Cell International, 21, 67. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
van’t Veer, L.J., Dai, H., van de Vijver, M.J., et al. (2002) Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer. Nature, 415, 530-536. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Burnett, R.M., Craven, K.E., Krishnamurthy, P., et al. (2015) Organ-Specific Adaptive Signaling Pathway Activation in Metastatic Breast Cancer Cells. Oncotarget, 6, 12682-12696. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Jin, H., Rugira, T., Ko, Y.S., et al. (2020) ESM-1 Overexpression Is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells. Cancers (Basel), 12, 1363. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Grigoriu, B.D., Depontieu, F., Scherpereel, A., et al. (2006) Endo-can Expression and Relationship with Survival in Human Non-Small Cell Lung Cancer. Clinical Cancer Research, 12, 4575-4582. [Google Scholar] [CrossRef]
|
|
[44]
|
Borczuk, A.C., Shah, L., Pearson, G.D., et al. (2004) Mo-lecular Signatures in Biopsy Specimens of Lung Cancer. American Journal of Respiratory and Critical Care Medicine, 170, 167-174. [Google Scholar] [CrossRef]
|
|
[45]
|
Paez, J.G., Jänne, P.A., Lee, J.C., et al. (2004) EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy. Science, 304, 1497-1500. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Yang, Y.C., Pan, K.F., Lee, W.J., et al. (2020) Circulating Proteo-glycan Endocan Mediates EGFR-Driven Progression of Non-Small Cell Lung Cancer. Cancer Research, 80, 3292-3304. [Google Scholar] [CrossRef]
|
|
[47]
|
Liu, N., Zhang, L.H., Du, H., et al. (2010) Overexpression of Endothelial Cell Specific Molecule-1 (ESM-1) in Gastric Cancer. Annals of Surgical Oncology, 17, 2628-2639. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Kang, Y.H., Ji, N.Y., Han, S.R., et al. (2012) ESM-1 Regulates Cell Growth and Metastatic Process through Activation of NF-κB in Colorectal Cancer. Cell Signal, 24, 1940-1949. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Zuo, L., Zhang, S.M., Hu, R.L., et al. (2008) Correlation between Expression and Differentiation of Endocan in Colorectal Cancer. World Journal of Gastroenterology, 14, 4562-4568. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Ding, D., Han, S., Zhang, H., et al. (2019) Predictive Biomarkers of Col-orectal Cancer. Computational Biology and Chemistry, 83, Article ID: 107106. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Xiang, X., Zhao, W.B. and Wang, X. (2009) Expression of ESM-1 in Hepatocellular Carcinoma Is Associated with Angiogenesis and Tumor Invasion. Chinese Journal of Hepatology, 17, 661-664.
|
|
[52]
|
Chen, L.Y., Liu, X., Wang, S.L., et al. (2010) Over-Expression of the Endocan Gene in Endothelial Cells from Hepatocellular Carcinoma Is Associated with Angiogenesis and Tumour Invasion. Journal of In-ternational Medical Research, 38, 498-510. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Huang, G.W., Tao, Y.M. and Ding, X. (2009) Endocan Expression Correlated with Poor Survival in Human Hepatocellular Carcinoma. Di-gestive Diseases and Sciences, 54, 389-394. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Kang, Y.H., Ji, N.Y., Lee, C.I., et al. (2011) ESM-1 Silencing Decreased Cell Survival, Migration, and Invasion and Modulated Cell Cycle Progression in Hepatocellular Carcinoma. Amino Acids, 40, 1003-1013. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Scheithauer, B.W., Kovacs, K.T., Laws, E.R., et al. (1986) Pa-thology of Invasive Pituitary Tumors with Special Reference to Functional Classification. Journal of Neurosurgery, 65, 733-744. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Cornelius, A., Cortet-Rudelli, C., Assaker, R., et al. (2012) Endothelial Expression of Endocan Is Strongly Associated with Tumor Progression in Pituitary Adenoma. Brain Pathology, 22, 757-764. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Miao, Y., Zong, M., Jiang, T., et al. (2016) A Comparative Analysis of ESM-1 and Vascular Endothelial Cell Marker (CD34/CD105) Expression on Pituitary Adenoma Invasion. Pituitary, 19, 194-201. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Rennel, E., Mellberg, S., Dimberg, A., et al. (2007) Endocan Is a VEGF-A and PI3K Regulated Gene with Increased Expression in Human Renal Cancer. Experimental Cell Research, 313, 1285-1294. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Leroy, X., Aubert, S., Zini, L., et al. (2010) Vascular Endocan (ESM-1) Is Markedly Overexpressed in Clear Cell Renal Cell Carcinoma. Histopathology, 56, 180-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Xu, H., Chen, X. and Huang, Z. (2019) Identification of ESM1 Overexpressed in Head and Neck Squamous Cell Carcinoma. Cancer Cell International, 19, 118. [Google Scholar] [CrossRef] [PubMed]
|